Cortisol, stress and depression

M. R. Garland

Beaumont Hospital, Dublin 9, Ireland.

Correspondence: E-mail: mgarland{at}ireland.com

The study of Strickland et al (2002) underpins the considerable inconsistency in the literature that addresses the area of peripheral markers in depression.

It has been argued that neuroendocrine challenge tests (such as the prolactin response to dexfenfluramine used by the authors) is not a valid probe of central neuronal function (for discussion see Weiss & Coccaro, 1997) and this may account for the negative findings of the study. More perplexing is the lack of association between depression and a reliable index of hypothalamic—pituitary—adrenal (HPA) axis activation, late-night salivary cortisol (reviewed by Kirschbaum & Hellhammer, 1994). In both humans and animals various models of acute and chronic stress (e.g. physical trauma, public speaking, caregiver stress in carers of people with Alzheimer's disease) are reliably associated with hyper-cortisolaemia (Kirschbaum & Hellhammer, 1994). If depression is considered to be an extreme form of chronic stress, why is there so little consistency between studies examining cortisol in populations with depression (Haskett, 1993)?

Strickland et al may have serendipitously discovered a crucial, if seemingly trivial, psycho-biological ‘co-factor’ in depression that dramatically distinguishes between cases with or without HPA axis activation: perceived stress (as measured by the Life Events and Difficulties Schedule (LEDS), see Strickland et al; p. 170, Fig. 1c). Equally depressed patients may not be equally ‘stressed’ and this may have biological as well as clinical consequences. The increased cardiac (Carney et al, 1997) and oncological (Persky et al, 1987) morbidity and mortality associated with depression may particularly apply to the depressed—stressed—hypercortisolaemic sub-group. Clearly more research is needed to explore this possibility.

EDITED BY KHALIDA ISMAIL

REFERENCES

Carney, R. M., Freedland, K. E., Sheline, Y. I., et al (1997) Depression and coronary heart disease: a review for cardiologists. Clinical Cardiology, 20, 196-200.[Medline]

Haskett, R. F. (1993) The HPA axis and depressive disorders. In Biology of Depressive Disorders, Part A: A Systems Perspective (eds J. J. Mann & D. J. Kupfer), pp. 171-189. New York: Plenum.

Kirschbaum, C. & Hellhammer, D. H. (1994) Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology, 19, 313-333.[Medline]

Persky, V. W., Kempthorne-Rawson, J. & Shekelle, R. B. (1987) Personality and risk of cancer: 20-year follow-up of the Western Electric Study. Psychosomatic Medicine, 49, 435-449.[Abstract]

Strickland, P. L., Deakin, J. F., Percival, C., et al (2002) Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission. British Journal of Psychiatry, 180, 168-173.[Abstract/Free Full Text]

Weiss, D. & Coccaro, E. F. (1997) Neuroendocrine challenge studies of suicidal behavior. Psychiatric Clinics of North America, 20, 563-579.[Medline]


 

Authors' reply

P. Strickland and J. F. W. Deakin

Neuroscience and Psychiatry Unit, Stopford Building, School of Psychiatry and Behavioural Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK

EDITED BY KHALIDA ISMAIL

Declaration of interest

The research conducted was funded by the Wellcome Trust.

In our study we found that recent severe life events were associated with increased salivary cortisol but that depression was not. This is incompatible with the widely held theory that stress predisposes to depression through its effects on the hypothalamic—pituitary—adrenal (HPA) axis. Dr Moore hopes that those with more severe depression may have shown evidence of cortisol hypersecretion. Unfortunately for the stress—HPA theory of depression there is no such evidence — not even in the 9 out of 94 cases with ICD-10 severe depression. The median 23.00 h cortisol levels are identical for the non-depressed subjects and those with depression at all levels of ICD-10 severity. For the 09.00 h cortisol levels, the ‘severe depression’ group median is 7.5 compared with 7.0 for the controls, with interquartile ranges of 5.75 and 5 respectively (i.e. almost total overlap between the groups).

Although it has become dogma that cortisol secretion is increased in depression, increased cortisol secretion is only reliably recorded in severe and often psychotic depression in hospital in-patients. We suggest that this reflects a primary disorder of the HPA in patients with bipolar and psychotic illness, which is unlikely to be connected with psychosocial stress. Our findings indicate that most depression occurs with normal or slightly reduced cortisol secretion and this finding is already present in the literature. For example, Stokes et al (1984) found that only 15-20% of subjects with depression in the community had elevated plasma cortisol concentrations. It seems inescapable that sustained hypercortisolaemia is not how social adversity causes depression. However, there is evidence from our study that depression is associated with sensitisation of the HPA axis to chronic stress. Chronic stress occurred in many non-depressed subjects but had no effect on cortisol, whereas in subjects with depression cortisol was increased in those who were chronically stressed. Therefore, increased cortisol in those with chronic stress is due to the depression and not vice versa; it is a marker for brain vulnerability to depression and not the proximal cause of the depressed state. As the findings of Maes et al (1994) suggest, the profound stress of admission to a psychiatric hospital may be the factor that induces hypercortisolaemia in hospital studies of depression, since cortisol was not increased in community patients with equal levels of depression. Similarly, as Garland importantly points out, degree of stress may be the key factor in determining physical morbidity and mortality associated with depression; the interaction of stress with being depressed may be all-important in determining the physical and psychiatric outcome of depression.

Contrary to Garland's assertion, the dexfenfluramine results were not ‘negative’; we found enhanced responses in the ‘depressed’ group. Perhaps he regards the failure to observe blunting in depression as a negative result. But our study is arguably the largest and best-controlled ever performed. Furthermore, exaggerated 5-HT2C responses in depression have been observed in studies using 5-hydroxytryptophan challenge (Meltzer et al, 1984). Serotonin abnormalities, like the cortisol response to chronic stress, may be seen as effects of depression. As Cowen points out in his commentary (Cowen, 2002), life events appear to increase fenfluramine responses only in the ‘depressed’ group. Fenfluramine responses were in fact lower (P < 0.1; Strickland et al, 2002: Fig. 1c) in the small number of depressed subjects without life-events. A small amount of serotonin release, induced by life events, playing onto super-sensitive 5-HT2C receptors together with subsensitive autoreceptors, could account for the exaggerated serotonin responses to life events in the ‘depressed’ group. If so, then biological vulnerability to depression could involve an underlying presynaptic impairment of serotonin function. On this interpretation, some of the symptoms of depression, such as anxiety, might still be mediated by unstable excessive stimulation of 5-HT2C receptors together with impaired 5-HT1A resilience mechanisms as suggested by Deakin & Graeff (1991). Dr Moore's suggestion that resistance to depression in the face of life events might be mediated by normal or enhanced serotonin responsiveness is compatible with this line of reasoning. However, his suggestion that life events act on a vulnerable serotonin system through cortisol responses is not compatible with our evidence — depression in the community is not associated with hypercortisolaemia.

REFERENCES

Cowen, P. J. (2002) Cortisol, serotonin and depression: all stressed out? British Journal of Psychiatry, 180, 99-100.[Free Full Text]

Deakin, J. F. & Graeff, F. G. (1991) 5-HT and mechanisms of defence. Journal of Psychopharmacology, 5, 305-315.

Maes, M., Calabrese, J. & Meltzer, H. Y. (1994) The relevance of the in- versus outpatient status for studies on HPA-axis in depression: spontaneous hypercortisolism is a feature of major depressed inpatients and not of major depression per se. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 18, 503-517.[Medline]

Meltzer, H. Y., Umberkoman, W. B., Robertson, A., et al (1984) Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania. Archives of General Psychiatry, 41, 366-374.[Abstract]

Stokes, P. E., Stoll, P. M., Koslow, S. H., et al (1984) Pretreatment DST and hypothalamic—pituitary—adrenocortical function in depressed patients and comparison groups. A multicentre study. Archives of General Psychiatry, 41, 257-267.[Abstract]

Strickland, P. J., Deakin, J. F. W., Percival, C., et al (2002) Bio-social origins of depression in the community. Interaction between social adversity, cortisol and serotonin neurotransmission. British Journal of Psychiatry, 180, 168-173.[Abstract/Free Full Text]





This Article
Submit a response
Alert me when this article is cited
Alert me when eLetters are posted
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Google Scholar
Articles by Garland, M. R.
Articles by Deakin, J. F. W.
Articles citing this Article
PubMed
PubMed Citation
Articles by Garland, M. R.
Articles by Deakin, J. F. W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals